Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients
Launched by ALEXANDRA HOSPITAL · Aug 9, 2023
Trial Information
Current as of May 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the EsoGLOVE, which is a soft robotic glove designed to help stroke patients improve their hand function during rehabilitation. The goal is to see if the EsoGLOVE, combined with special sensors that track muscle activity, can assist patients in doing exercises and daily tasks, ultimately helping them recover better and regain movement in their hands. The researchers also want to understand how cost-effective this device is for healthcare.
To participate in this study, you need to be between 30 and 90 years old and have had an ischemic or hemorrhagic stroke. You should be in stable health and able to follow simple commands. Participants will be involved in exercises using the EsoGLOVE while being monitored for their progress. It’s important to note that patients with certain conditions, such as severe depression or unstable medical issues, won't be eligible for this trial. Overall, this study aims to gather important information that could lead to better rehabilitation options for stroke patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 30-90 years regardless of lesion size, race
- • 2. Stroke type: ischemic or haemorrhagic
- • 3. Medically stable conditions
- • 4. Fugl-Meyer Assessment (FMA) of upper extremity impairment of 10-56 out of 66.
- • 5. Able to give own consent, comprehend and follow commands
- • 6. Able to sit upright and maintain sitting balance for at least 30 minutes
- • 7. Able to stay alert and focus on the tasks at least 30 minutes and more.
- • 8. Unilateral upper limb impairment
- Exclusion Criteria:
- • 1. Recurrent stroke
- • 2. Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of \<1 year.
- • 3. Cognitive and communicative impairment (e.g. severe receptive aphasia, inattention, learning difficulty, and etc).
- • 4. History of severe depression or active psychiatric disorder.
- • 5. Severe spasticity (Modified Ashworth scale ≥2), joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel).
- • 6. Poor trunk control or postural hypotension.
About Alexandra Hospital
Alexandra Hospital is a leading healthcare institution dedicated to advancing patient care through innovative clinical research and trials. With a commitment to excellence, the hospital focuses on a wide range of medical specialties, fostering an environment that encourages collaboration among healthcare professionals, researchers, and patients. By integrating cutting-edge technology and evidence-based practices, Alexandra Hospital aims to enhance treatment outcomes and contribute to the global body of medical knowledge. The institution prioritizes patient safety and ethical standards, ensuring that all clinical trials are conducted with the utmost integrity and transparency.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Singapore, , Singapore
Patients applied
Trial Officials
Pui Kit Tam, MBBS
Principal Investigator
Alexandra Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported